Shoji Ozeki
Nagoya City University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shoji Ozeki.
Journal of Pharmacy and Pharmacology | 1987
Jun Watanabe; Ineko Koyama; Kikuo Iwamoto; Shoji Ozeki
Flow rate, protein level and pH of mandibular and parotid saliva samples in rats were almost stabilized 2h after induction of salivation with pilocarpine (9ṁ0 mg h−1 kg−1). Salivary excretion profiles of procainamide, 50 mg kg−1 i.v., and its metabolite N‐acetylprocainamide (NAPA) were then investigated. Plasma and salivary procainamide levels declined bi‐exponentially with time almost in parallel. Salivary procainamide levels (Y) from both types of gland were correlated with the plasma level (X) over a wide concentration range [Y = 0ṁ108X + 1ṁ96 (r = 0ṁ795) for mandibular and Y = 0ṁ917X (r = 0ṁ974) for parotid glands]. The mean saliva to plasma concentration ratio (S/P ratio) was significantly higher in parotid (0ṁ974 ± 0ṁ243) than in mandibular (0ṁ284 05119) saliva samples. Similar correlations and S/P ratios were observed for NAPA. Procainamide and NAPA mean S/P ratios for saliva from both glands were fairly consistent with the calculated value according to the pH‐partition hypothesis.
Pharmaceutical Research | 1985
Jun Watanabe; Tsutomu Setoyama; Kikuo Iwamoto; Yayoi Hayashi; Shoji Ozeki
Indomethacin was measured in mandibular and parotid saliva, obtained from separate cannulas in the salivary ducts, after bolus intravenous administration (15 mg/kg) to male white rabbits that were stimulated for salivation with pilocarpine given subcutaneously. There was a significant correlation between each salivary drug concentration and plasma drug concentration. Saliva to plasma drug concentration ratio (S/P ratio) and pH were higher in mandibular saliva than in parotid saliva. These gland specific differences were in contrast with the previously reported differences in dogs. Matins equation was found to predict approximately the mean observed S/P ratio of indomethacin for each saliva sample.
Chemical & Pharmaceutical Bulletin | 1985
Jun Watanabe; Yayoi Hayashi; Kikuo Iwamoto; Shoji Ozeki
Biological & Pharmaceutical Bulletin | 1994
Hiroaki Yuasa; Michie Sekiya; Shoji Ozeki; Jun Watanabe
Journal of Pharmaceutical Sciences | 1995
Hiroaki Yuasa; Wataru Numata; Shoji Ozeki; Jun Watanabe
Journal of pharmacobio-dynamics | 1983
Jun Watanabe; Katsuyuki Hori; Kikuo Iwamoto; Shoji Ozeki
Journal of pharmacobio-dynamics | 1981
Jun Watanabe; Yasuko Nakase; Yoshimi Urasaki; Yayoi Hayashi; Kikuo Iwamoto; Shoji Ozeki
Chemical & Pharmaceutical Bulletin | 1974
Tyotaro Tukamoto; Shoji Ozeki; Fujio Hattori; Takashi Ishida
Journal of pharmacobio-dynamics | 1982
Jun Watanabe; Katsuyuki Hori; Kikuo Iwamoto; Shoji Ozeki
Journal of pharmacobio-dynamics | 1989
Yayoi Hayashi; Jun Watanabe; Shoji Ozeki